Review
doi: 10.1046/j.1464-410x.2003.04494.x.
The management of hormone-relapsed prostate cancer
Affiliations
- PMID: 14616436
- DOI: 10.1046/j.1464-410x.2003.04494.x
Item in Clipboard
Review
The management of hormone-relapsed prostate cancer
BJU Int.
2003 Nov.
No abstract available
Comment in
-
The management of hormone-relapsed prostate cancer.BJU Int. 2004 May;93(7):1115. doi: 10.1111/j.1464-410X.2004.4834b.x. BJU Int. 2004. PMID: 15142178 No abstract available.
Similar articles
-
Manifestations of advanced prostate cancer: prognosis and treatment.J Urol. 1989 Oct;142(4):921-8. doi: 10.1016/s0022-5347(17)38943-7. J Urol. 1989. PMID: 2677414 Review. No abstract available.
-
Quality of life of patients with advanced and metastatic prostatic carcinoma.Eur Urol. 1993;24 Suppl 2:118-21. doi: 10.1159/000474402. Eur Urol. 1993. PMID: 8262116 Review.
-
The management of hormone-relapsed prostate cancer.BJU Int. 2004 May;93(7):1115. doi: 10.1111/j.1464-410X.2004.4834b.x. BJU Int. 2004. PMID: 15142178 No abstract available.
-
Management of pain and other symptoms of advanced prostatic cancer.Semin Urol. 1988 Nov;6(4):311-21. Semin Urol. 1988. PMID: 3068769 Review. No abstract available.
-
Management of the spectrum of hormone refractory prostate cancer.Eur Urol. 2006 Sep;50(3):428-38; discussion 438-9. doi: 10.1016/j.eururo.2006.05.017. Epub 2006 Jun 2. Eur Urol. 2006. PMID: 16797118 Review.
Cited by
-
A phase 2 study of high-activity 186Re-HEDP with autologous peripheral blood stem cell transplant in progressive hormone-refractory prostate cancer metastatic to bone.Eur J Nucl Med Mol Imaging. 2006 Sep;33(9):1055-61. doi: 10.1007/s00259-005-0010-5. Epub 2006 Mar 30. Eur J Nucl Med Mol Imaging. 2006. PMID: 16572306 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical